Abstract: The present disclosure provides a terminal vibration evaluation method performed by an electronic device. The method includes: acquiring an actual vibration curve of a target terminal when a target game scenario is displayed; acquiring a predefined vibration description file associated with the target game scenario, and determining a predefined vibration curve according to the predefined vibration description file; determining target deviation data between the actual vibration curve and the predefined vibration curve; and determining, according to the target deviation data, whether vibration of the target terminal matches the target game scenario. The present disclosure provides a measurement solution used for determining whether terminal vibration matches a game scenario (for example, a game sound and a game picture), which helps improve a matching degree between terminal vibration and the game scenario, thereby improving a sense of substitution of the game and a sense of immersion of a player.

Abstract: The present invention relates to a fibrotic disease mechanism, and a preventive/therapeutic drug and method therefor. The present invention can improve the level of cAMP by means of a PDE inhibitor such as dipyridamole to treat fibrotic diseases and inhibit the progress of fibrosis. The present invention further achieves anti-inflammatory and immune regulation effects, and achieves a therapeutic effect on all aspects of the occurrence and development of fibrosis.

Abstract: The present disclosure discloses a method for preparing rare earth oxide by recycling ammonia and carbon, comprising the steps of: (1) heating raw materials containing a first rare earth carbonate and a first rare earth oxide with microwave and calcining at 500-1000° C. for 20-120 min to obtain a second rare earth oxide and carbon dioxide; (2) reacting carbon dioxide with a first ammonia water to obtain a precipitant; (3) reacting the precipitant with rare earth chloride to obtain a second rare earth carbonate and ammonium chloride wastewater. In the method, calcination time is short, rare earth recovery rate, utilization rate of ammonia and carbon resources are high. The present disclosure also provides a use of a rare earth oxide in shortening calcination time and/or increasing rare earth yield.

Abstract: The invention relates to an electronically commutated electric motor with a stator and a rotor, which is designed as a permanent magnet rotor in particular. The electric motor also has a control unit which is connected to the stator. The control unit is designed to generate control signals for energizing the stator coils of the stator in order to generate a rotational magnetic field. The electric motor is designed to at least partly compensate for a torque ripple of a torque generated by the rotor. According to the invention, the electric motor has a rotor position sensor and a current sensor. The current sensor is designed to detect currents flowing in the stator coils and to generate a current signal which represents the currents.

Abstract: The invention relates to an electronically commutated electric motor with a stator and a rotor, which is designed as a permanent magnet rotor in particular. The electric motor also has a control unit which is connected to the stator. The control unit is designed to generate control signals for energizing the stator coils of the stator in order to generate a rotational magnetic field. The electric motor is designed to at least partly compensate for a torque ripple of a torque generated by the rotor. According to the invention, the electric motor has a rotor position sensor and a current sensor. The current sensor is designed to detect currents flowing in the stator coils and to generate a current signal which represents the currents.

Abstract: Atomic coordinates for human serine/threonine protein phosphotase 2A (PP2A) holoenzyme, as well as methods for using these atomic coordinates to prepare inhibitors of PP2A and inhibitors prepared using such methods are provided herein. A biochemical analysis of the interactions of PP2A holoenzyme is also provided. Compositions including mimetics and small molecules of the invention and, optionally, secondary agents may be used to treat disorders in which PP2A activity plays a contributing role.

Abstract: Embodiments of the present invention relate to crystals and atomic coordinates for PP2A, as well as methods for using these atomic coordinates to prepare modulators of PP2A and inhibitors prepared using such methods. Further embodiments relate to biochemical analyses of the interactions of PP2A alone or in complex with Tau. Further embodiments relate to compositions including mimetics and small molecules, optionally, secondary agents, which may be used to treat disorders in which PP2A activity and/or Tau plays a contributing role.